4//SEC Filing
Ajer Jeffrey Robert 4
Accession 0001048477-24-000030
CIK 0001048477other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:32 PM ET
Size
4.7 KB
Accession
0001048477-24-000030
Insider Transaction Report
Form 4
Ajer Jeffrey Robert
SVP, Chief Commercial Of
Transactions
- Sale
Common Stock
2024-03-05$87.07/sh−4,000$348,280→ 94,047 total
Footnotes (1)
- [F1]Trade made pursuant to a 10b5-1 plan executed on April 13, 2023.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0001557533
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 5:32 PM ET
- Size
- 4.7 KB